Autopsy report · NCT04523727
Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Registered 1 year 10 months before it started.
- Suspended: paused, and may or may not restart.
- 45 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 3
- Sponsor
- Keryx Biopharmaceuticals
- Sponsor type
- Industry
- Conditions
- Hyperphosphatemia Related to Chronic Kidney Disease
- Interventions
- ferric citrate
- Participants
- 45 (planned, not actual)
- Sites
- 14
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.